Immunovant, Inc. (IMVT)
33.64
+0.47
(+1.42%)
USD |
NASDAQ |
Nov 19, 09:41
Immunovant Price : 33.64 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 33.07 | 34.23 | 32.59 | 33.17 | 907607.0 |
| Nov 17, 2026 | 33.17 | 33.82 | 32.45 | 33.21 | 926731.0 |
| Nov 16, 2026 | 33.86 | 34.52 | 33.04 | 33.28 | 1.054M |
| Nov 13, 2026 | 34.71 | 34.84 | 33.87 | 34.18 | 864882.0 |
| Nov 12, 2026 | 36.92 | 36.92 | 34.86 | 35.05 | 1.183M |
| Nov 11, 2026 | 35.77 | 37.59 | 35.52 | 37.04 | 1.712M |
| Nov 10, 2026 | 35.15 | 35.98 | 34.83 | 35.71 | 1.644M |
| Nov 09, 2026 | 33.32 | 35.61 | 32.81 | 35.15 | 3.979M |
| Nov 06, 2026 | 28.73 | 30.61 | 28.34 | 30.53 | 2.659M |
| Nov 05, 2026 | 29.78 | 29.83 | 28.12 | 28.39 | 1.121M |
| Nov 04, 2026 | 29.82 | 29.93 | 28.50 | 29.90 | 1.270M |
| Nov 03, 2026 | 28.70 | 29.48 | 28.42 | 29.04 | 1.080M |
| Nov 02, 2026 | 29.32 | 29.64 | 28.38 | 28.41 | 1.268M |
| Oct 30, 2026 | 29.49 | 29.78 | 28.76 | 29.17 | 1.165M |
| Oct 29, 2026 | 29.56 | 30.15 | 29.33 | 29.64 | 1.399M |
| Oct 28, 2026 | 28.50 | 29.47 | 28.42 | 29.42 | 1.243M |
| Oct 27, 2026 | 28.25 | 28.96 | 28.00 | 28.88 | 1.058M |
| Oct 26, 2026 | 28.46 | 28.50 | 27.62 | 28.17 | 1.195M |
| Oct 23, 2026 | 28.93 | 28.93 | 28.14 | 28.41 | 641437.0 |
| Oct 22, 2026 | 28.09 | 29.12 | 27.98 | 29.10 | 1.157M |
| Oct 21, 2026 | 28.97 | 29.18 | 28.05 | 28.38 | 1.495M |
| Oct 20, 2026 | 27.76 | 29.14 | 27.62 | 28.59 | 1.449M |
| Oct 19, 2026 | 27.12 | 27.84 | 26.52 | 27.62 | 1.375M |
| Oct 16, 2026 | 27.42 | 27.42 | 26.28 | 26.73 | 1.463M |
| Oct 15, 2026 | 28.03 | 28.33 | 27.48 | 27.51 | 1.649M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roivant Sciences Ltd. | 39.00 |
| Ionis Pharmaceuticals, Inc. | 27.51 |
| Vertex Pharmaceuticals, Inc. | 534.99 |
| Heron Therapeutics, Inc. | 0.2706 |
| TG Therapeutics, Inc. | 66.33 |
Price Related Metrics
| Price to Book Value | 10.59 |
| Earnings Yield | -7.58% |
| Market Cap | 6.956B |